Biocon Gets A New Group CEO As Aflibercept Approval Arrives

Peter Bains Named As New Chief; Yesafili Biosimilar Is Europe’s First Eylea Rival

 
• By David Wallace
  
CEO 3d rendering
Biocon has named Peter Bains as group CEO
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Leadership

More from Generics Bulletin